RESEARCHERS: ADDF-Harrington Scholar Award

PhD or MD or equivalent required for eligibility.

Letters of Intent (LOI) Due [DEADLINE EXTENDED]: June 9, 2025

Harrington Discovery Institute and the Alzheimer's Drug Discovery Foundation (ADDF) invite you to submit a letter of intent (LOI) for the 2026 ADDF-Harrington Scholar Award. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer's disease and related dementias. Of particular interest are targets related to proteostasis and senescence. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer's field are strongly encouraged to apply. In addition to grant funding, Harrington Discovery Institute provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.

Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers' feedback to help the applicant strengthen the proposal for future submission.

Visit our website to learn more about the ADDF-Harrington Scholar program.

To submit your LOI online, go to ADDF's grant system and create an account.

Questions? Email [email protected] or [email protected].

Scientific inquiries? Email Meriel Owen, PhD, ADDF at [email protected].